title: Pre-exposure prophylaxis for the prevention of HIV infection: a new prevention paradigm?
abstract: Pre-exposure prophylaxis" (PrEP) has been recently developed as a prevention strategy which involves the administration of drugs to non-infected individuals who present high exposure or susceptibility to HIV. Although this use is not approved in our country, several guidelines recommend PrEP as a prevention option in adult MSM, heterosexual men and women, and users of parenteral drugs at risk of acquiring the infection. This article presents the characteristics that an ideal agent to be used as PrEP should meet, recent efficacy published data and barriers for the implementation of this new strategy. On the other hand, the role of hospital pharmacists will be discussed.
authors.affiliation: Hospital Universitario de Getafe, Madrid.. javier.sanchez@salud.madrid.org.
authors.forename: Javier
authors.initials: J
authors.lastname: Sánchez-Rubio Ferrández
authors.affiliation: Hospital Virgen de La Salud, Toledo. Spain.. jmmartinezs@gmail.com.
authors.forename: José Manuel
authors.initials: JM
authors.lastname: Martínez Sesmero
mesh_terms: D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D065129:Pre-Exposure Prophylaxis